Citation:Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, et al 1999

Citation

Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999 Sep;17(9):2692-9 Available from: http://www.ncbi.nlm.nih.gov/pubmed/10561343.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S, et al 1999	What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?	Dr Adelaide Morgan	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?|]] (compare critical appraisals)

Cited by

1. What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?
2. What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage I NSCLC?